111 Capital’s Balchem Corp BCPC Stock Holding History

111 Capital’s Portfolio BCPC Stock Details BCPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,206	Closed	-$200K	–	717
2025 Q1	$200K	Buy	+1,206	New	+$198K	0.04%	414

Other funds holding BCPC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

111 Capital's BCPC Position: Q2 2025 in Review

111 Capital sold out of Balchem Corp (BCPC) in Q2 2025, closing a stake of 1,206 shares — an estimated $200K sold.

111 Capital first reported a position in BCPC in Q1 2025 and held it in 1 quarter. The position peaked at $200K in Q1 2025. 396 funds tracked by Wall St. Rank hold BCPC as of Q2 2025.

111 Capital reported no remaining Balchem Corp position as of Q2 2025 after selling out during the quarter.
111 Capital sold 1,206 Balchem Corp shares in Q2 2025, an estimated $200K.
111 Capital first reported a position in Balchem Corp in Q1 2025 and held it in 1 quarter.
111 Capital's Balchem Corp position peaked at $200K in Q1 2025.
396 funds tracked by Wall St. Rank held Balchem Corp as of Q2 2025.

Based on 111 Capital's 13F filing for Q2 2025, filed 21 Jul 2025.